Table 1.
Baseline characteristics according to different SHR tertiles
| Variables | Total | SHR tertiles | p-value | ||
|---|---|---|---|---|---|
| SHR1 (≤ 0.982) | SHR2 (0.982–1.329) | SHR3 (≥ 1.329) | |||
| n | 5417 | 1809 | 1804 | 1804 | |
| Clinical characteristics | |||||
| Age (years) | 65 (54–72) | 64 (53–71) | 65 (55–72) | 65 (56–72) | < 0.001 |
| Female,n (%) | 1641 [30.29%] | 502 [27.75%] | 489 [27.11%] | 650 [36.03%] | < 0.001 |
| Weight (Kg) | 65 (60–70) | 65 (60–75) | 67 (60–75) | 65 (60–75) | 0.072 |
| SBP (mmHg) | 125 (110–140) | 125 (110–140) | 128 (110–142) | 120 (105–140) | < 0.001 |
| DBP (mmHg) | 80 (70–90) | 80 (70–90) | 80 (70–90) | 80 (69–90) | 0.006 |
| HR (beats/min) | 76 (64–88) | 76 (64–86) | 75 (64–86) | 77 (64–90) | 0.001 |
| Killip | < 0.001 | ||||
| 1 | 4415 [81.50%] | 1522 [84.13%] | 1519 [84.20%] | 1374 [76.16%] | |
| 2 | 648 [11.96%] | 197 [10.89%] | 200 [11.09%] | 251 [13.91%] | |
| 3 | 199 [3.67%] | 56[3.10%] | 48 [2.66%] | 95 [5.27%] | |
| 4 | 155 [2.86%] | 34 [1.88%] | 37 [2.05%] | 84 [4.66%] | |
| Angina | 442 [8.16%] | 140 [7.74%] | 152 [8.43%] | 150 [8.31%] | 0.721 |
| Anterior STE or LBBB | 2862 [52.83%] | 989 [54.67%] | 941 [52.16%] | 932 [51.66%] | 0.152 |
| Hypertension | 2177 [40.19%] | 676 [37.37%] | 727 [40.30%] | 775 [42.96%] | 0.003 |
| Diabetes mellitus | 1336 [24.66%] | 627 [34.66%] | 296 [16.41%] | 413 [22.89%] | < 0.001 |
| Prior stroke | 520 [9.60%] | 145 [8.02%] | 172 [9.53%] | 203 [11.25%] | 0.004 |
| TIMI class | < 0.001 | ||||
| 1 | 2415 [44.58%] | 849 [46.93%] | 863 [47.84%] | 703 [38.96%] | |
| 2 | 2113 [39.01%] | 695 [38.42%] | 691 [38.30%] | 727 [40.30%] | |
| 3 | 889 [16.41%] | 265 [14.65%] | 250 [13.86%] | 374 [20.73%] | |
| Laboratory tests | |||||
| Glucose(mmol/L) | 7.4 (6.0–9.8) | 5.7 (5.0–6.4) | 7.2 (6.5–8.2) | 11 (9.0–14.9) | < 0.001 |
| HbA1c(%) | 5.7 (5.3–6.4) | 6.0 (5.6–6.8) | 5.6 (5.3–6.1) | 5.6 (5.2–6.3) | < 0.001 |
| Hemoglobin(g/L) | 135 (124–148) | 136 (124–147) | 136 (124–148) | 135 (122–147) | 0.406 |
| Reperfusion therapy | |||||
| Primary PCI | 691 [12.76%] | 166 [9.18%] | 251 [13.91%] | 274 [15.19%] | < 0.001 |
| Thrombolytic therapy | 2747 [50.71%] | 880 [48.65%] | 913 [50.61%] | 954 [52.88%] | 0.039 |
| Culprit lesion | 0.041 | ||||
| LAD Artery | 382 [7.05%] | 97 [5.36%] | 136 [7.54%] | 149 [8.26%] | |
| RCA Artery | 239 [4.41%] | 50 [2.76%] | 81 [4.49%] | 108 [5.99%] | |
| LCX Artery | 70 [1.30%] | 18 [1.00%] | 34 [1.88%] | 18 [1.00%] | |
| Medications | |||||
| Antiplatelet therapy | 5225 [96.46%] | 1730 [95.63%] | 1757 [97.39%] | 1738 [96.34%] | 0.016 |
| Statins | 3927 [72.49%] | 1338 [73.96%] | 1328 [73.61%] | 1261 [69.90%] | 0.010 |
| β-blockers | 2954 [54.53%] | 1102 [60.92%] | 1167 [64.69%] | 1087 [60.25%] | 0.013 |
| ACEI/ARB | 3874 [71.52%] | 1312 [72.53%] | 1306 [72.39%] | 1256 [69.62%] | 0.092 |
| Diuretics | 758 [13.99%] | 213 [11.77%] | 216 [11.97%] | 329 [18.24%] | < 0.001 |
ABG admission blood glucose, ACEI angiotensin-Converting Enzyme Inhibitors, ARB Angiotensin Receptor Blocker, DBP diastolic blood pressure, HR heart rate, LAD left anterior descending, LCX left circumflex, RCA right coronary artery, SBP systolic blood pressure, SHR stress hyperglycemia ratio, STE ST-segment elevation, LBBB, left bundle-branch block